International Journal of Pharmaceutical and Phytopharmacological Research
ISSN (Print): 2250-1029
ISSN (Online): 2249-6084
Publish with eIJPPR Submission
2026   Volume 16   Issue 2

Agentic AI for Computational Pharmacology: Orchestrating Molecular Search, Evidence Appraisal, Mechanistic Reasoning, and Candidate Prioritization
Download PDF


, ,
  1. Department of AI for Dead Sea and Desert Plant Adaptogens, Faculty of Pharmacy, University of Jordan, Amman, Jordan.
  2. Department of Machine Learning for Kinase Inhibition, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.
Citation
Vancouver
Hassan L, Khalaf O, Jaber R. Agentic AI for Computational Pharmacology: Orchestrating Molecular Search, Evidence Appraisal, Mechanistic Reasoning, and Candidate Prioritization. Int J Pharm Phytopharmacol Res. 2026;16(2):123-35. https://doi.org/10.51847/5TFFxnr14x
APA
Hassan, L., Khalaf, O., & Jaber, R. (2026). Agentic AI for Computational Pharmacology: Orchestrating Molecular Search, Evidence Appraisal, Mechanistic Reasoning, and Candidate Prioritization. International Journal of Pharmaceutical And Phytopharmacological Research, 16(2), 123-135. https://doi.org/10.51847/5TFFxnr14x
Download citation:   EndNote   RIS
Article Link:
Downloads: 25
Views: 67
Abstract

Agentic artificial intelligence is emerging as a potential approach for coordinating complex computational research workflows that require multiple searches, tools, reasoning stages, and review checkpoints. In computational pharmacology, such coordination may support the integration of molecular search, literature retrieval, evidence appraisal, target and pathway interpretation, safety assessment, and candidate prioritization. This article proposes a conceptual agentic AI framework designed to organize these activities while preserving source grounding, pharmacological caution, auditability, and human decision authority. The framework separates molecular and evidence-retrieval functions from source-quality appraisal, mechanistic reasoning, safety review, and multi-criteria prioritization. It further introduces explicit controls for tool permissions, evidence provenance, citation traceability, conflict detection, uncertainty communication, expert escalation, and validation planning. Molecular search outputs are treated as research hypotheses rather than validated candidates, while mechanistic interpretations are framed as evidence-linked plausibility assessments rather than confirmation of biological mechanism. Candidate rankings are similarly restricted to provisional decision-support outputs that require pharmacological, medicinal-chemistry, toxicological, and experimental review. The principal contribution is a structured architecture in which specialized agents can assist task decomposition and evidence organization without independently establishing biological truth, safety, efficacy, translational readiness, or clinical utility. By embedding human oversight and validation boundaries throughout the workflow, the proposed framework positions agentic AI as a research-orchestration approach rather than an autonomous drug discovery or clinical decision-making system.

Related articles:
Most viewed articles:
Naproxen in Pain and Inflammation – A Review
Vol 11 Issue 1, 2021 | Svetoslav Nikolaev Stoev
An Overview on Emulgel
Vol 9 Issue 1, 2019 | Sreevidya V.S
Volume 16
Issue 4
2026

Call for Papers
[email protected]
Issues
Associations
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2026 International Journal of Pharmaceutical and Phytopharmacological Research
Authors retain copyright of their article if they are accepted for publication.